UCB, Inc. v. Actavis Laboratories UT, Inc.
UCB PHARMA GMBH, UCB, INC. and LTS LOHMANN THERAPIE-SYSTEME AG |
ACTAVIS LABORATORIES UT, INC. |
21-1924 |
May 6, 2021 |
U.S. Court of Appeals, Federal Circuit |
Other |
Opinions
We have the following opinions for this case:
Description |
---|
UCB, Inc. v. Actavis Laboratories UT, Inc. |
UCB, INC. v. ACTAVIS LABORATORIES UT, INC. |
Docket Report
This docket was last retrieved on June 15, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 13 Entry of appearance for Anthony D. Raucci as counsel for Appellants LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and UCB, Inc.. Service: 06/15/2021 by email. [780439] [21-1924] [Anthony Raucci] [Entered: 06/15/2021 02:56 PM] |
Filing 12 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 10 ], ERROR: The Certificate of Interest is incomplete. CORRECTION: For future filings, please include Question #6. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [777755] [EKD] [Entered: 06/01/2021 08:58 AM] |
Filing 11 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 10 ] filed by Appellants UCB, Inc., LTS Lohmann Therapie-Systeme AG, and UCB Pharma GmbH. The opening brief is due 08/05/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [777754] [EKD] [Entered: 06/01/2021 08:56 AM] |
Filing 10 MOTION of Appellants UCB, Inc., UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG to extend the time to 08/05/2021 to file brief. Service: 05/28/2021 by email. [777665] [21-1924] [James Trainor] [Entered: 05/28/2021 04:09 PM] |
Filing 9 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 6 ], Doc No. [ # 7 ], Doc No. [ # 8 ], ERROR: The documents contain non-compliant signatures. CORRECTION: For future filings, please use an electronic signature consisting of the printed name of the individual preceded by the mark /s/ entered on the signature line. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [776405] [EKD] [Entered: 05/21/2021 09:33 AM] |
Filing 8 Docketing Statement for the Appellants UCB, Inc., UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG. Service: 05/20/2021 by email. [776367] [21-1924] [James Trainor] [Entered: 05/20/2021 05:35 PM] |
Filing 7 Certificate of Interest for Appellants UCB, Inc., UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG. Service: 05/20/2021 by email. [776366] [21-1924] [James Trainor] [Entered: 05/20/2021 05:29 PM] |
Filing 6 Entry of appearance for James S. Trainor; Kevin X. McGann; Silvia M. Medina; Catherine H. McCord; Jack B. Blumenfeld; Derek J. Fahnestock as counsel for Appellants UCB, Inc., UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG. Service: 05/20/2021 by email. [776360] [21-1924] [James Trainor] [Entered: 05/20/2021 05:18 PM] |
Filing 5 Entry of appearance for George Frank Pappas; Richard L. Rainey; Alexa Hansen; Alaina Marie Whitt as counsel for Appellants LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and UCB, Inc.. Service: 05/20/2021 by email. [776268] [21-1924] [Alaina Whitt] [Entered: 05/20/2021 02:24 PM] |
Filing 4 Docketing Statement for the Appellee Actavis Laboratories UT, Inc.. Service: 05/20/2021 by email. [776198] [21-1924] [William Burgess] [Entered: 05/20/2021 11:25 AM] |
Filing 3 Certificate of Interest for Appellee Actavis Laboratories UT, Inc.. Service: 05/20/2021 by email. [776197] [21-1924] [William Burgess] [Entered: 05/20/2021 11:25 AM] |
Filing 2 Entry of appearance for John C. O'Quinn; William H. Burgess; Christopher T. Jagoe; Thomas F. Fleming as counsel for Appellee Actavis Laboratories UT, Inc.. Service: 05/20/2021 by email. [776196] [21-1924] [William Burgess] [Entered: 05/20/2021 11:23 AM] |
Filing 1 Appeal docketed. Received: 05/03/2021. [773389] Entry of Appearance is due on 05/20/2021. Certificate of Interest is due on 05/20/2021. Docketing Statement is due on 05/20/2021. Appellants' brief is due on 07/06/2021. [EKD] [Entered: 05/06/2021 12:57 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.